| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.23 | 0.01 |